GGrantIndex
Sort

51,593 grants matching hepatitis

Malaria Vaccine Based on Self-Assembling Polypeptide Nanoparticles (SAPN)

$543,351
Peter Burkhard · University Of Connecticut Storrs · R01 · FY2011 · AI

COMT Genotype and Risky Decision Making in HIV and Methamphetamine Dependence

$543,350
Mariana Cherner · University Of California, San Diego · R01 · FY2009 · DA

MICHIGAN DEPT. OF COMMUNITY HEALTH VIRAL HEPATITIS PREVENTION COORDINATION & SURE

$543,303
Kathryn Emery Macomber · Michigan State Department Of Health And Human Services · U51 · FY2015 · PS

Sustainable HIV Risk Reduction Strategies for CJ Systems

$543,284
Wayne E.k. Lehman · Texas Christian University · R01 · FY2017 · DA

Metabolomic Assessment of Estrogenic Endocrine Disruptor

$543,226
Timothy R Zacharewski · Michigan State University · R01 · FY2007 · ES

Metabolic Syndrome in PCOS: Precursors and Interventions

$543,225
Andrea Dunaif · Northwestern University At Chicago · R01 · FY2006 · DK

Technology-Dev-Core

$543,199
Sally M McFall · Northwestern University · U54 · FY2019 · EB

Immunology of Acute and Chronic Viral Hepatitis in Humans

$543,182
Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2010 · DK

Nanochelation Therapies for Iron Overload Disorders

$543,043
Jonghan Kim · University Of Massachusetts Lowell · R01 · FY2021 · HL

Improving hepatocellular carcinoma mouse modeling by understanding the malignant potential and biology of liver cell subpopulations

$543,031
Hao Zhu · Ut Southwestern Medical Center · R01 · FY2021 · CA

Male IDUs in Viet Nam: Ethno-Epidemiology of HIV Risk

$542,951
Michael C. Clatts · University Of Puerto Rico Med Sciences · R01 · FY2008 · DA

Non-invasive screening of diabetics for advanced fibrosis due to NAFLD

$542,792
Rohit Loomba · University Of California, San Diego · R01 · FY2021 · DK

Studies on RNAi Based Delivery in Vivo

$542,790
Mark A Kay · Stanford University · R01 · FY2011 · DK

BU Clinical HIV/AIDS Research Training Program (BU-CHART

$542,752
Benjamin P Linas · Boston Medical Center · T32 · FY2024 · AI

Personal and social-built environmental factors of glucose variability among multi ethnic groups of adults with type 2 diabetes

$542,727
Soohyun Nam · Yale University · R01 · FY2023 · DK

Quantifying Body Composition and Liver Disease in Children using Free-Breathing MRI and MRE

$542,722
Holden H Wu · University Of California Los Angeles · R01 · FY2023 · DK

Malaria Pathogenesis in young children and vaccine discovery

$542,662
Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Improving hepatocellular carcinoma mouse modeling by understanding the malignant potential and biology of liver cell subpopulations

$542,616
Hao Zhu · Ut Southwestern Medical Center · R01 · FY2020 · CA

Liver Pathobiology and Gene Therapy Research Core Center

$542,609
Allan W Wolkoff · Albert Einstein College Of Medicine, Inc · P30 · FY2018 · DK

Alpha2/delta1- thrombospondin-3 signaling in the central control of metabolic function

$542,580
Maribel Rios · Tufts University Boston · R01 · FY2024 · DK

Hepatitis C Virus Immunobiology and Pathogenesis

$542,558
Francis Vincent Chisari · Scripps Research Institute, The · R01 · FY2007 · CA

NATURAL HISTORY OF HEPATITIS C INFECTION IN HIV DISEASE

$542,549
Boston Medical Center · R01 · FY2003 · DK

Signaling and metabolic functions of nSMase-2 in hepatic steatosis and onset of insulin resistance

$542,521
Mariana Nikolova-Karakashian · University Of Kentucky · R01 · FY2023 · DK

The Role of the Intestinal Mycobiome in Alcoholic Liver Disease

$542,520
Bernd G. Schnabl · University Of California, San Diego · R01 · FY2022 · AA

HCV-specific T cell response

$542,488
Research Inst Nationwide Children'S Hosp · R37 · FY2005 · AI